These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 18650794

  • 1. Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis.
    Kumar S, Fan SL, Raftery MJ, Yaqoob MM.
    Kidney Int; 2008 Oct; 74(7):946-51. PubMed ID: 18650794
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease.
    Li L, Szeto CC, Kwan BC, Chow KM, Leung CB, Kam-Tao Li P.
    Am J Kidney Dis; 2011 Jun; 57(6):903-7. PubMed ID: 21458901
    [Abstract] [Full Text] [Related]

  • 4. Outcomes of patients with autosomal-dominant polycystic kidney disease on peritoneal dialysis: A meta-analysis.
    Boonpheng B, Thongprayoon C, Wijarnpreecha K, Medaura J, Chebib FT, Cheungpasitporn W.
    Nephrology (Carlton); 2019 Jun; 24(6):638-646. PubMed ID: 29952039
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical outcomes and mortality in peritoneal dialysis patients: a 10-year retrospective analysis in a single center.
    Unsal A, Koc Y, Basturk T, Sakaci T, Ahbap E, Sinangil A, Budak SK, Sevinc M, Kara E, Doner B.
    Clin Nephrol; 2013 Oct; 80(4):270-9. PubMed ID: 23816475
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Factors predicting survival in patients on peritoneal dialysis].
    Leaños-Miranda A.
    Rev Invest Clin; 1997 Oct; 49(5):355-60. PubMed ID: 9580052
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nocturnal Hemodialysis Compared with Conventional Dialysis for End-Stage Renal Disease Treatment in Polycystic Kidney Disease Patients.
    Xue C, Sun B, Ye X, Zhou C, Yang B, Zhang L, Yu S.
    Blood Purif; 2020 Oct; 49(1-2):85-92. PubMed ID: 31722330
    [Abstract] [Full Text] [Related]

  • 16. Outcome and complications in peritoneal dialysis patients: a five-year single center experience.
    Alwakeel JS, Alsuwaida A, Askar A, Memon N, Usama S, Alghonaim M, Feraz NA, Shah IH, Wilson H.
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):245-51. PubMed ID: 21422621
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of AA amyloidosis on survival in peritoneal dialysis.
    Koc Y, Basturk T, Unsal A, Sakaci T, Ahbap E, Sinangil A, Budak SK, Sevinc M, Kayalar AO, Doner B.
    Kidney Blood Press Res; 2012 Mar; 36(1):182-90. PubMed ID: 23147073
    [Abstract] [Full Text] [Related]

  • 19. Is peritoneal dialysis a therapeutic option for polycystic kidney disease? 15 years' experience in a single center.
    Koc Y, Basturk T, Sakaci T, Atan Ucar Z, Ahbap E, Sevinc M, Sinangil A, Kara E, Ozdemir Kayalar A, Bayraktar Caglayan F, Sahutoglu T, Baris Hasbal N, Ünsal A.
    Nephrol Ther; 2016 Jul; 12(4):215-20. PubMed ID: 27320369
    [Abstract] [Full Text] [Related]

  • 20. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F, Camerin E, Feriani M, Nordio M, Piccoli A, Rossi B, Tessitore N.
    G Ital Nefrol; 2009 Jul; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.